Page last updated: 2024-08-24

triazoles and pd 0325901

triazoles has been researched along with pd 0325901 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrero, MJ; Brooks, HB; Campbell, RM; García-Carpizo, V; Graña, O; Han, B; Pisano, DG; Ruiz-Llorente, S; Sarmentero, J; Serrano, M	1
Beltran, P; Caenepeel, S; Cajulis, E; Cooke, K; Coxon, A; Huang, G; Hughes, PE; Kendall, R; Moreno, BH; Parisi, G; Ribas, A; Robert, L; Wadsworth, S	1

Other Studies

2 other study(ies) available for triazoles and pd 0325901

Article	Year
NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. Scientific reports, 2016, 09-08, Volume: 6 Topics: Animals; Azepines; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Enhancer Elements, Genetic; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression; Gene Knockdown Techniques; Genes, ras; Histone-Lysine N-Methyltransferase; Histones; Humans; Lung Neoplasms; MAP Kinase Kinase Kinases; Methylation; Mice; Mice, Nude; Nuclear Proteins; Repressor Proteins; Transcription Factors; Transcription, Genetic; Triazoles; Xenograft Model Antitumor Assays	2016
MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor. Oncotarget, 2017, Mar-14, Volume: 8, Issue:11 Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Dipeptides; Diphenylamine; Drug Resistance, Neoplasm; Female; Hepatocyte Growth Factor; Humans; Indoles; MAP Kinase Signaling System; Melanoma; Mice; Mice, Nude; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Pyridones; Sulfonamides; Triazoles; Vemurafenib; Xenograft Model Antitumor Assays	2017

Article

Year

NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.

Scientific reports, 2016, 09-08, Volume: 6

Topics: Animals; Azepines; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Enhancer Elements, Genetic; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression; Gene Knockdown Techniques; Genes, ras; Histone-Lysine N-Methyltransferase; Histones; Humans; Lung Neoplasms; MAP Kinase Kinase Kinases; Methylation; Mice; Mice, Nude; Nuclear Proteins; Repressor Proteins; Transcription Factors; Transcription, Genetic; Triazoles; Xenograft Model Antitumor Assays

2016

MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor.

Oncotarget, 2017, Mar-14, Volume: 8, Issue:11

Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Dipeptides; Diphenylamine; Drug Resistance, Neoplasm; Female; Hepatocyte Growth Factor; Humans; Indoles; MAP Kinase Signaling System; Melanoma; Mice; Mice, Nude; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Pyridones; Sulfonamides; Triazoles; Vemurafenib; Xenograft Model Antitumor Assays

2017